Skip to content

Current ratio at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
4.6×-0.4×
Theravance Biopharma logo
Theravance BiopharmaTBPH
13.1×+8.4×
Savara logo
SavaraSVRA
13.5×-1.4×
LQD
Liquidia CorporationLQDA
2.2×-0.7×
United Therapeutics logo
United TherapeuticsUTHR
4.8×-0.7×
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
1.2×-0.2×

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-47.3%
Enterprise value$50.17M-43.5%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×

Where this comes from

Calculated from Pulmonx Corporation’s reported figures.

Based on the most recent quarter.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's current ratio?
Pulmonx Corporation (LUNG) reported current ratio of 4.9× in Q1 2026.
How has Pulmonx Corporation's current ratio changed year-over-year?
Pulmonx Corporation's current ratio decreased by 1.3% year-over-year, from 5× to 4.9×.
What is the long-term trend for Pulmonx Corporation's current ratio?
Over 5 years (2020 to 2025), Pulmonx Corporation's current ratio has grown at a -24.0% compound annual growth rate (CAGR), from 20× to 5.1×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.